Uchida M, Otsubo K, Matsubara J, Ohtani T, Morita S, Yamasaki K
Tokushima Research Institute, Japan.
Chem Pharm Bull (Tokyo). 1995 Apr;43(4):693-8. doi: 10.1248/cpb.43.693.
In search for inhibitors of gastric H+/K+-ATPase, 4-(phenylamino)quinoline-3-carboxamides were synthesized and evaluated for antisecretory activity against histamine-induced gastric acid secretion in rats. These compounds were synthesized by condensation of aniline derivatives with N-substituted 4-chloroquinoline-3-carboxamides, which were obtained from treatment of 4(1H)-quinolinone-3-carboxylic acid with thionyl chloride. Most of the compounds inhibited histamine-induced gastric acid secretion in rats. Among them, N-allyl-4-(2-ethylphenylamino)quinoline-3-carboxamide (4h) was the most potent inhibitor and had the best profile as a candidate antiulcer agent. This compound showed reversible, K+-competitive gastric H+/K+-ATPase inhibitory activity.
为寻找胃H⁺/K⁺-ATP酶抑制剂,合成了4-(苯胺基)喹啉-3-甲酰胺,并评估其对组胺诱导的大鼠胃酸分泌的抗分泌活性。这些化合物通过苯胺衍生物与N-取代的4-氯喹啉-3-甲酰胺缩合而成,后者由4(1H)-喹啉酮-3-羧酸与亚硫酰氯反应制得。大多数化合物能抑制组胺诱导的大鼠胃酸分泌。其中,N-烯丙基-4-(2-乙基苯胺基)喹啉-3-甲酰胺(4h)是最有效的抑制剂,作为抗溃疡候选药物具有最佳特性。该化合物表现出可逆的、K⁺竞争性的胃H⁺/K⁺-ATP酶抑制活性。